久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

美國LipoScience
LipoScience是領先的生物分析診斷公司，主要使用核磁共振方法（NMR）通過分析血液中脂蛋白的成分進行心血管疾病的分級。這項技術由于北卡州立大學生物化學專家James Otvos提出，他目前是該公司的首席科學顧問。測試結果目前已廣泛得到Mdeicare，TRICARE，WellPoint，United HealthCare 等醫療保險公司認可。
LipoScience 開創了一個基于 NMR 技術進行個性化診斷的新領域。加強并拓寬我們的專有診斷測試能力

LipoScience is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes* and other metabolic diseases are assessed and managed.

We develop proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample.

Over 8 million tests performed since 1999 to benefit physicians and their patients. This test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes.

The company is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care.

We have broad opportunities for growth in our diagnostic, research, and laboratory businesses. We are actively pursuing these opportunities with the support of our employees, our customers, and our industry partners.

* The LP-IR test is only available through the LipoScience laboratory.